479612-36-7 Usage
Description
6-Chloro-3-methyl-4-pyridinemethanol is a chemical compound with the molecular formula C7H8ClNO. It is an organic compound that belongs to the class of pyridinemethanols. This white to off-white crystalline solid is soluble in water and is commonly used as a reagent in organic synthesis and pharmaceutical research. Due to its pharmacological properties, it also has potential applications in the development of drugs and pharmaceutical formulations, making it a versatile compound in the field of chemistry and pharmaceuticals.
Uses
Used in Organic Synthesis:
6-Chloro-3-methyl-4-pyridinemethanol is used as a reagent in organic synthesis for its ability to facilitate various chemical reactions, contributing to the creation of a wide range of organic compounds.
Used in Pharmaceutical Research:
In pharmaceutical research, 6-Chloro-3-methyl-4-pyridinemethanol is utilized as a key intermediate in the development of new drugs, aiding in the synthesis of pharmaceutically active molecules.
Used in Drug Development:
6-Chloro-3-methyl-4-pyridinemethanol is used in the development of drugs and pharmaceutical formulations due to its pharmacological properties, which can be harnessed to create new therapeutic agents.
Used in Chemical Industry:
6-Chloro-3-methyl-4-pyridinemethanol is used as a versatile building block in the chemical industry for the synthesis of various chemical products, including agrochemicals and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 479612-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,9,6,1 and 2 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 479612-36:
(8*4)+(7*7)+(6*9)+(5*6)+(4*1)+(3*2)+(2*3)+(1*6)=187
187 % 10 = 7
So 479612-36-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H8ClNO/c1-5-3-9-7(8)2-6(5)4-10/h2-3,10H,4H2,1H3
479612-36-7Relevant articles and documents
INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION
-
, (2020/03/01)
Sultam compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
Potent N-(1,3-Thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel
Bilodeau, Mark T.,Balitza, Adrienne E.,Koester, Timothy J.,Manley, Peter J.,Rodman, Leonard D.,Buser-Doepner, Carolyn,Coll, Kathleen E.,Fernandes, Christine,Gibbs, Jackson B.,Heimbrook, David C.,Huckle, William R.,Kohl, Nancy,Lynch, Joseph J.,Mao, Xianzhi,McFall, Rosemary C.,McLoughlin, Debra,Miller-Stein, Cynthia M.,Rickert, Keith W.,Sepp-Lorenzino, Laura,Shipman, Jennifer M.,Subramanian, Raju,Thomas, Kenneth A.,Wong, Bradley K.,Yu, Sean,Hartman, George D.
, p. 6363 - 6372 (2007/10/03)
A series of N-(1,3-thiazol-2-yl)pyridin-2-amine KDR kinase inhibitors have been developed that possess optimal properties. Compounds have been discovered that exhibit excellent in vivo potency. The particular challenges of overcoming hERG binding activity and QTc increases in vivo in addition to achieving good pharmacokinetics have been acomplished by discovering a unique class of amine substituents. These compounds have a favorable kinase selectivity profile that can be accentuated with appropriate substitution.
